[Target Molecule for a Demyelinating Type of Guillain-Barré Syndrome, Acute Inflammatory Demyelinating Polyneuropathy].

@article{Mori2015TargetMF,
  title={[Target Molecule for a Demyelinating Type of Guillain-Barr{\'e} Syndrome, Acute Inflammatory Demyelinating Polyneuropathy].},
  author={Masahiro Mori},
  journal={Brain and nerve = Shinkei kenkyu no shinpo},
  year={2015},
  volume={67 11},
  pages={1359-69}
}
Guillain-Barré syndrome is classified into demyelinating type, acute inflammatory demyelinating polyneuropathy (AIDP) and axonal form, acute axonal motor neuropathy (AMAN). It has been clearly established that the target molecule for the former is a ganglioside. In contrast, despite years of effort, the target molecule for the latter has not been identified… CONTINUE READING